Selecta Biosciences, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 06/21/2022   Download
SEC Document
SEC Filing
On June 17, 2022, Selecta Biosciences, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders, at which the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Restated Certificate of Incorporation (the “Charter”) to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share, from 200,000,000 to 350,000,000 shares.

The Company’s board of directors previously approved the Amendment and, on June 21, 2022, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) to the Charter with the Secretary of State of the State of Delaware. The Certificate of Amendment became effective on June 21, 2022 upon filing with the Secretary of State of the State of Delaware.